Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0007137|squamous cell carcinoma |
Sentences | 2 |
PubMedID- 20539208 | A phase 1 safety study of an irx-2 regimen in patients with squamous cell carcinoma of the head and neck. |
PubMedID- 24124338 | Aim: to evaluate the efficacy and safety of paclitaxel-nedaplatin combination as a front-line regimen in chinese patients with metastatic esophageal squamous cell carcinoma (escc). |
Page: 1